[go: up one dir, main page]

NO20032261D0 - Medisinske preparater - Google Patents

Medisinske preparater

Info

Publication number
NO20032261D0
NO20032261D0 NO20032261A NO20032261A NO20032261D0 NO 20032261 D0 NO20032261 D0 NO 20032261D0 NO 20032261 A NO20032261 A NO 20032261A NO 20032261 A NO20032261 A NO 20032261A NO 20032261 D0 NO20032261 D0 NO 20032261D0
Authority
NO
Norway
Prior art keywords
pharmacologically acceptable
pharmaceutical composition
esters
acceptable salts
medical preparations
Prior art date
Application number
NO20032261A
Other languages
English (en)
Other versions
NO20032261L (no
NO332938B1 (no
Inventor
Toshio Sada
Makoto Mizuno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032261(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20032261D0 publication Critical patent/NO20032261D0/no
Publication of NO20032261L publication Critical patent/NO20032261L/no
Publication of NO332938B1 publication Critical patent/NO332938B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
NO20032261A 2000-11-21 2003-05-20 Farmasoytisk preparat som inneholder en spesifikk angiotensin II-reseptor-antagonist og hydroklortiazid, og anvendelsen derav for fremstilling av det farmasoytiske medikament for forebygging eller behandling av hypertensjon hos varmblodige dyr NO332938B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31
PCT/JP2001/010095 WO2002041890A1 (en) 2000-11-21 2001-11-19 Medicinal compositions

Publications (3)

Publication Number Publication Date
NO20032261D0 true NO20032261D0 (no) 2003-05-20
NO20032261L NO20032261L (no) 2003-07-09
NO332938B1 NO332938B1 (no) 2013-02-04

Family

ID=26604360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032261A NO332938B1 (no) 2000-11-21 2003-05-20 Farmasoytisk preparat som inneholder en spesifikk angiotensin II-reseptor-antagonist og hydroklortiazid, og anvendelsen derav for fremstilling av det farmasoytiske medikament for forebygging eller behandling av hypertensjon hos varmblodige dyr

Country Status (23)

Country Link
US (2) US6878703B2 (no)
EP (2) EP1336407B1 (no)
KR (1) KR100656716B1 (no)
CN (1) CN1265788C (no)
AT (1) ATE324890T1 (no)
AU (2) AU1432402A (no)
BR (1) BR0115516A (no)
CA (1) CA2429260A1 (no)
CY (1) CY1106134T1 (no)
CZ (1) CZ20031367A3 (no)
DE (1) DE60119368T2 (no)
DK (1) DK1336407T3 (no)
ES (1) ES2262689T3 (no)
HU (1) HUP0400553A3 (no)
IL (2) IL155965A0 (no)
MX (1) MXPA03004463A (no)
NO (1) NO332938B1 (no)
NZ (1) NZ525913A (no)
PL (1) PL207252B1 (no)
PT (1) PT1336407E (no)
SK (1) SK5992003A3 (no)
TW (1) TWI262076B (no)
WO (1) WO2002041890A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101194453B1 (ko) * 2003-01-31 2012-10-24 다이이찌 산쿄 가부시키가이샤 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
EP1667643A4 (en) 2003-08-28 2008-03-05 Nitromed Inc NITROSIS AND NITROSYL CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
KR100953878B1 (ko) * 2004-09-02 2010-04-22 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
EP1706401A1 (en) * 2004-09-02 2006-10-04 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
CA2597460A1 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
JP5000491B2 (ja) * 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
WO2006123766A1 (ja) * 2005-05-20 2006-11-23 Daichi Sankyo Company, Limited デキストロース含有フィルムコーティング製剤
WO2007047838A2 (en) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
ATE526963T1 (de) * 2006-05-04 2011-10-15 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit olmesartan- medoxomil
KR100963389B1 (ko) * 2006-10-30 2010-06-14 한올바이오파마주식회사 시간차로 방출되는 치아자이드계 화합물과 안지오텐신―ⅱ―수용체 차단제를 포함하는 약학적 조성물
EP2253318B1 (en) 2008-03-13 2014-08-06 Daiichi Sankyo Company, Limited Improvement of dissolvability of preparation containing olmesartan medoxomil
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US9387249B2 (en) 2008-12-23 2016-07-12 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
JP2021528735A (ja) 2018-06-14 2021-10-21 アストラゼネカ・ユーケイ・リミテッドＡｓｔｒａＺｅｎｅｃａ ＵＫ Ｌｉｍｉｔｅｄ アンジオテンシンｉｉ受容体遮断薬医薬組成物による高血圧症の治療方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976289A (en) 1961-03-21 X-tetrahydro -
US3025292A (en) 1962-03-13 Reduction of i
US3009911A (en) 1961-11-21 Derivatives of j
US3108097A (en) 1963-10-22 Ehnojs
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US3254076A (en) 1966-05-31 Sulfamyl hydro
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
BE639386A (no) 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0733366B1 (en) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IS1756B (is) * 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
US5310928A (en) 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
KR20030096235A (ko) 2003-12-24
US20040002529A1 (en) 2004-01-01
EP1595540A1 (en) 2005-11-16
ES2262689T3 (es) 2006-12-01
PT1336407E (pt) 2006-07-31
DE60119368D1 (de) 2006-06-08
HUP0400553A3 (en) 2010-03-29
NO20032261L (no) 2003-07-09
CA2429260A1 (en) 2002-05-30
CN1486182A (zh) 2004-03-31
AU1432402A (en) 2002-06-03
ATE324890T1 (de) 2006-06-15
US20050113367A1 (en) 2005-05-26
CZ20031367A3 (cs) 2003-10-15
NO332938B1 (no) 2013-02-04
NZ525913A (en) 2004-05-28
MXPA03004463A (es) 2003-08-19
BR0115516A (pt) 2004-02-03
TWI262076B (en) 2006-09-21
PL361093A1 (en) 2004-09-20
HUP0400553A2 (hu) 2004-06-28
PL207252B1 (pl) 2010-11-30
AU2002214324B2 (en) 2004-07-29
DE60119368T2 (de) 2007-05-03
EP1336407A1 (en) 2003-08-20
EP1336407A4 (en) 2004-07-14
CN1265788C (zh) 2006-07-26
IL155965A0 (en) 2003-12-23
KR100656716B1 (ko) 2006-12-13
DK1336407T3 (da) 2006-09-04
CY1106134T1 (el) 2011-06-08
SK5992003A3 (en) 2003-11-04
US6878703B2 (en) 2005-04-12
HK1054692A1 (en) 2003-12-12
IL155965A (en) 2008-08-07
WO2002041890A1 (en) 2002-05-30
EP1336407B1 (en) 2006-05-03

Similar Documents

Publication Publication Date Title
NO20032261D0 (no) Medisinske preparater
EA200501075A1 (ru) Лекарственное средство для профилактики и лечения артериосклероза и гипертензии
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE60237145D1 (de) Chinazolinderivate
BR0206955A (pt) Ligantes de receptores de canabinóides
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
ATE204873T1 (de) Naphthyridinderivate als angiotensin-ii- antagonist-inhibitoren
ATE297203T1 (de) Antithrombotische mitteln
PT1337535E (pt) Derivados de benzodiazepina
SE9904508D0 (sv) New compounds
TR200202466T2 (tr) Felç, diyabet ve/veya konjesif kalp yetmezliğinin önlenmesinde kullanılan farmakolojik formülasyonlar.
ATE311358T1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
WO2003049690A3 (en) Hiv integrase inhibitors
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
TR199800165T1 (xx) (R)-5-bromo-n-(1-etil-4-metil hekzahidro-1h-1,4-diazepin-6-il)-2-metoksi-6- metilamino-3-piridinkarboksamid, bunu haz�rlamaya mahsus y�ntem ve bu bile�i�i ihtiva eden farmas�tik terkip.
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
WO2002026732A1 (en) Benzodiazepine derivative
DE60034545D1 (de) Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
DE60022047D1 (de) Antivirale therapie
EP1806136A4 (en) MEDICAL COMPOSITION PREVENTING THE TRANSITION TO OPERATIVE TREATMENT IN PROSTATE HYPERTROPHY
ATE270886T1 (de) Antivirale therapie

Legal Events

Date Code Title Description
MK1K Patent expired